The immediate effect of triceps surae myofascial trigger point therapy on restricted active ankle joint dorsiflexion in recreational runners: a crossover randomised controlled trial
Review
-
Fascial
J Bodyw Mov Ther.2013 Oct;17(4):453-61.
Authors:
Rob Grieve, Amy Cranston, Andrew Henderson, Rachel John, George Malone, Christopher Mayall
Abstract.
Objectives: To investigate the immediate effect on restricted active ankle joint dorsiflexion range of motion (ROM), after a single intervention of myofascial trigger point (MTrP) therapy on latent triceps surae MTrPs in recreational runners. Design: A crossover randomised controlled trial. Participants: Twenty-two recreational runners (11 men and 11 women; mean age 24.57; ±8.7 years) with a restricted active ankle joint dorsiflexion and presence of latent MTrPs. Intervention: Participants were screened for a restriction in active ankle dorsiflexion in either knee flexion (soleus) or knee extension (gastrocnemius) and the presence of latent MTrPs. Participants were randomly allocated a week apart to both the intervention (combined pressure release and 10 s passive stretch) and the control condition. Results: A clinically meaningful (large effect size) and statistically significant increase in ankle ROM in the intervention compared to the control group was achieved, for the soleus (p = 0.004) and the gastrocnemius (p = 0.026). Conclusion: Apart from the statistical significance (p < 0.05), these results are clinically relevant due to the immediate increase in ankle dorsiflexion. These results must be viewed in caution due to the carry-over effect in the RCT crossover design and the combined MTrP therapy approach.
Publication Date:
2013 Oct
OEID:
6532
Grieve, R., Cranston, A., Henderson, A., John, R., Malone, G., Mayall, C. (2013) 'The immediate effect of triceps surae myofascial trigger point therapy on restricted active ankle joint dorsiflexion in recreational runners: a crossover randomised controlled trial', J Bodyw Mov Ther.2013 Oct;17(4):453-61.
Sponsored by
Search Explore About Join Web Policy Contact Us
Copyright © 2023 OsteoEvidence. All Rights Reserved.